Absci ABSI
Jump To Section
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Absci (ABSI) Business Model and Operations Summary
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Key Insights
Absci (ABSI) Stock Information & Key Business Metrics
Latest Closing Price
$3.32Market Cap
$569.68 MillionAverage Daily Volume
5,277,092 Shares52-Week Range
$2.01-$6.33Price-Earnings Ratio
-3.46Total Outstanding Shares
149.52 Million SharesCEO
Sean McClainTotal Employees
157Current Dividend
No dividendIPO Date
July 22, 2021SIC Description
Services-commercial Physical & Biological ResearchHeadquarters
18105 Se Mill Plain Blvd, Vancouver, WA, 98683